NCT03677076View on ClinicalTrials.gov

Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Prostate Cancer
Interventions
OTHER

Ancillary/Correlative

Collection of research blood and urine

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03677076 - Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter